In the Czech Republic, pure CBD is not a scheduled substance under Czech law; the legality of the use of isolate and extracts – which have to always be THC-free – depends on additional regulations according to each product category. This regulatory report offers a thorough overview and analysis of the current regulatory regime in place in the Czech Republic, covering all laws and restrictions in relation to extracts and finished products, and medical and recreational cannabis.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
This report will enable you to identify pricing differences and the range of pricing for product types across different markets, understand possible reasoning for pricing differences across different markets, and identify price points for strategy development and price setting.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
Table of contents
